Does ERENUMAB Cause Hypercholesterolaemia? 113 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Hypercholesterolaemia have been filed in association with ERENUMAB (AIMOVIG). This represents 9.6% of all adverse event reports for ERENUMAB.
113
Reports of Hypercholesterolaemia with ERENUMAB
9.6%
of all ERENUMAB reports
113
Deaths
105
Hospitalizations
How Dangerous Is Hypercholesterolaemia From ERENUMAB?
Of the 113 reports, 113 (100.0%) resulted in death, 105 (92.9%) required hospitalization, and 106 (93.8%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERENUMAB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does ERENUMAB Cause?
Off label use (293)
Migraine (285)
Drug ineffective (280)
Gastrooesophageal reflux disease (236)
Drug intolerance (227)
Vomiting (220)
Pain (217)
Abdominal pain upper (210)
Blepharospasm (209)
Hypoaesthesia (204)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which ERENUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
ERENUMAB vs ERENUMAB-AOOE
ERENUMAB vs ERENUMAB\ERENUMAB-AOOE
ERENUMAB vs ERGOCALCIFEROL
ERENUMAB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB vs ERIBULIN